Skip to content
2000
Volume 17, Issue 3
  • ISSN: 1570-1611
  • E-ISSN: 1875-6212

Abstract

Chronic venous disease (CVeD) is a highly prevalent condition in the general population, and it has a significant impact on quality of life. While it is usually manifested by obvious signs, such as varicose veins and venous ulcers, other symptoms of the disease are less specific. Among the other symptoms, which include heaviness, swelling, muscle cramps and restless legs, pain is the symptom that most frequently compels CVeD patients to seek medical aid. However, there is a substantial discrepancy between pain severity and clinically detectable signs of CVeD, questioned by several opposing studies. Further evaluation is needed to clarify this subject, and to analyse whether pain development predicts objective CVeD progression. General management of CVeD starts with advising lifestyle changes, such as lowering body mass index and treating comorbidities. However, the mainstay of treatment is compression therapy, with the additional use of pharmacological substances. Venoactive drugs proved to be the drugs of choice for symptom alleviation and slowing the progression of CVeD, with micronized purified flavonoid fraction being the most effective one. Interventional therapy is reserved for advanced stages of the disease.

Loading

Article metrics loading...

/content/journals/cvp/10.2174/1570161116666180209111826
2019-05-01
2025-06-27
Loading full text...

Full text loading...

/content/journals/cvp/10.2174/1570161116666180209111826
Loading

  • Article Type:
    Review Article
Keyword(s): Chronic venous disease; hypertension; pain; spinal cord; treatment; venoactive drugs
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test